Every doctor will know the moment. The appointment is drawing to a close, the patient is gathering their things, and then ...
Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help guide management.
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...